3-136250377-TG-AA
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_000532.5(PCCB):c.2_3delTGinsAA(p.Met1?) variant causes a start lost change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000532.5 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCCB | NM_000532.5 | c.2_3delTGinsAA | p.Met1? | start_lost | ENST00000251654.9 | NP_000523.2 | ||
PCCB | NM_001178014.2 | c.2_3delTGinsAA | p.Met1? | start_lost | NP_001171485.1 | |||
PCCB | XM_011512873.2 | c.2_3delTGinsAA | p.Met1? | start_lost | XP_011511175.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Propionic acidemia Pathogenic:1
This sequence change affects the initiator methionine of the PCCB mRNA. The next in-frame methionine is located at codon 84. For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the PCCB protein in which other variant(s) (p.His59Gln) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 1968405). This variant has not been reported in the literature in individuals affected with PCCB-related conditions. Information on the frequency of this variant in the gnomAD database is not available, as this variant may be reported differently in the database. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.